Fibromyalgia Tender Points Explained: What They Mean Clinically | ALIV

Many patients who come to ALIV's Pune and Mumbai clinics have encountered the "fibromyalgia tender points" concept — the idea that a fibromyalgia diagnosis requires pressing on specific body locations and counting how many are painful. Some have been told they "only had twelve of eighteen" and therefore do not have fibromyalgia. Some have been diagnosed solely on the basis of tender point count without a complete clinical picture. Understanding what tender points actually represent — and why the current diagnostic standard has moved beyond them — makes a meaningful difference to patients navigating the diagnostic process.

What Tender Points Originally Represented

The 18-point tender point examination was introduced in the 1990 American College of Rheumatology fibromyalgia classification criteria. It involved a clinician pressing on 18 predetermined bilateral anatomical locations with approximately 4kg of pressure, and counting how many produced pain on palpation. A count of 11 or more was required for classification as fibromyalgia. The 18 points are located at specific anatomical sites: the occiput (base of skull), cervical spine, trapezius (shoulder area), supraspinatus, second rib junction, lateral epicondyle (outer elbow), gluteal (buttock), greater trochanter (outer hip), and medial knee — 9 bilateral pairs.

These tender points were selected because they were consistently found to be more tender in fibromyalgia patients than in healthy controls or patients with other pain conditions. They reflect areas of high nociceptor density and mechanosensitivity that are predictably hypersensitive in central sensitisation. They are not "trigger points" (the specific taut bands in myofascial pain syndrome) and they are not related to the location of the worst pain — they are standardised examination sites that efficiently demonstrate widespread hyperalgesia.

Why the 1990 Tender Point System Was Replaced

The 1990 criteria were classification criteria (designed for research) rather than diagnostic criteria (designed for clinical practice), but came to be used clinically — creating problems. Tender point counts are highly variable between examiners and examination sessions; they are significantly affected by patient emotional state and anxiety; and the 11-of-18 threshold excluded real fibromyalgia patients with fewer tender points but significant symptom burden — and included some patients with localised pain conditions. The criteria also emphasised physical examination at the expense of the cognitive and fatigue symptoms that are central to the fibromyalgia experience.

The 2010 and 2016 revised ACR criteria replaced the tender point count with two patient-reported scales: the Widespread Pain Index (WPI — a count of body areas in which the patient has had pain in the past week, out of 19 defined areas) and the Symptom Severity Scale (SSS — a 0–12 score covering fatigue, cognitive symptoms, and unrefreshed sleep). A fibromyalgia diagnosis requires WPI ≥ 7 and SSS ≥ 5, or WPI 4–6 and SSS ≥ 9, with symptoms present for at least three months and no other clinical explanation. Physical examination remains part of the clinical picture but the rigid tender point count is no longer the diagnostic arbiter. See: complete fibromyalgia diagnosis guide.

What the Tender Point Examination Still Tells Us

While the tender point count is no longer the diagnostic gatekeeper, examining tenderness at these sites remains clinically useful. It provides objective evidence of widespread pressure hyperalgesia — a direct physical demonstration of central sensitisation. A patient who experiences significant pain on light palpation at multiple tender point sites provides the clinician with an objective correlate to the subjective pain report. This can be reassuring to patients who have felt their pain was not believed — the tender point examination demonstrates it physically. It is also useful for tracking treatment response: patients with improving fibromyalgia typically show increasing pressure pain thresholds on serial tender point examinations over time.

ALIV's Approach to Tender Point Assessment

At ALIV, tender point assessment is integrated into the broader clinical evaluation of fibromyalgia patients — used as one data point alongside the WPI and SSS, sleep history, nutritional blood markers, and psychosocial history. The Fibromyalgia Relief IV programme is initiated based on the comprehensive clinical picture, not solely on any single examination finding. Serial assessment of tenderness thresholds is one of the markers used to track response to IV magnesium and nutritional support over the course of treatment.

Does a tender point examination hurt?

In fibromyalgia patients with significant central sensitisation, yes — the examination can be genuinely painful, especially at the more sensitive sites. A skilled examiner applies standardised pressure (approximately 4kg, often gauged by using the examiner's thumb until the thumbnail blanches) and records the response. The patient is asked to report whether the stimulus is painful (not just uncomfortable or tender). An experienced examiner can conduct the examination efficiently and will stop if the patient's distress is significant. The discomfort is short-lived — the value of confirming the objective hyperalgesia typically outweighs the brief procedural discomfort.

If I have pain everywhere, why do the tender points focus on specific spots?

The 18 tender point sites were empirically selected because they are the locations that most reliably differentiate fibromyalgia from other pain conditions — not because they are necessarily the worst pain locations in any individual patient. In fibromyalgia, the widespread hyperalgesia means that almost any area will be more sensitive than normal; the specific sites are a standardised sampling approach. Many fibromyalgia patients are more symptomatic in areas not included in the formal tender point map — low back, abdomen, lower legs — which is one reason the shift to the broader WPI body map is more clinically representative.

Can tender points resolve with treatment?

Yes — pressure pain threshold at tender point sites measurably improves with effective fibromyalgia management. This has been demonstrated in clinical trials of aerobic exercise, low-dose amitriptyline, and multimodal management programmes. The improvement in tender point hyperalgesia reflects the reduction in central sensitisation that effective treatment produces — the nervous system's amplification is turning down, and the same amount of pressure now produces less pain. This objective measurable change is one of the most useful treatment response markers in fibromyalgia management.

Are tender points the same as trigger points?

No — these are distinct clinical entities frequently confused in patient and even clinical conversations. Trigger points (from myofascial pain syndrome) are hyperirritable spots in specific taut bands of skeletal muscle that produce referred pain in a predictable pattern when pressed. They are a peripheral musculoskeletal phenomenon. Tender points (fibromyalgia) are areas of generalised pressure hyperalgesia reflecting central sensitisation — they do not produce referred pain patterns and are not located in taut bands. Myofascial pain syndrome and fibromyalgia can coexist, which adds clinical complexity, but treating trigger points does not address fibromyalgia central sensitisation and vice versa.